Navigation Links
Rochester Medical Announces New Opportunity in the United Kingdom
Date:9/21/2009

STEWARTVILLE, Minn., Sept. 21 /PRNewswire-FirstCall/ -- Rochester Medical Corporation (Nasdaq: ROCM) today announced that the Company's FemSoft(R) Insert has been approved for inclusion in Part IX of the UK Drug Tariff as a prescription product which is reimbursable.

There are no other products listed in the Drug Tariff specifically for managing female stress urinary incontinence, and the Company believes that for many women this will be a very welcome addition that offers a discreet, non-surgical, odor-free, secure, and safe alternative to absorbents.

FemSoft(R) Inserts are particularly effective in situations where leakage occurs during certain physical activities such as exercise, coughing, laughing, or sneezing.

Hugh McLeod, General Manager of the U.K. business commented that this represents a significant opportunity for Rochester Medical and will enhance the Company's position as the leading worldwide innovator and marketer of silicone continence care devices.

He noted that the FemSoft(R) Insert product line fits perfectly alongside Rochester Medical's current portfolio of catheters for intermittent self-catheterization and will be marketed through the same customer base of Urology Nurse Specialists and Continence Nurse Specialists.

Commenting on the news, Anthony J. Conway Rochester Medical CEO and President said, "This is excellent news for women in the United Kingdom and also great news for Rochester Medical. We believe the FemSoft(R) Insert provides an elegant non-surgical, comfortable, and dry alternative to absorbents. Earlier this year we announced that U.S. Medicare has given preliminary reimbursement approval to the FemSoft Insert, and we expect final confirmation in the near future. In both the U.K. and U.S. we expect implementation of the reimbursement to begin in January 2010, and we are making sales and marketing preparations accordingly."

About Rochester Medical

Rochester Medical is the world's leading manufacturer of all-silicone catheters for urological and continence care applications. Our advanced line of latex-free products features male external catheters, intermittent catheters, Foley catheters and urethral inserts as well as latex-free accessories.

More information about Rochester Medical is available on its website at http://www.rocm.com.

Forward-Looking Statement

This press release contains "forward-looking statements" that are based on currently available information, operating plans and management's expectations about future events and trends. They inherently involve risks and uncertainties that could cause actual results to differ materially from those predicted in such forward-looking statements, including the uncertainty of estimated revenues and profits, the uncertainty of current domestic and international economic conditions that could adversely affect the level of demand for the Company's products and increased volatility in foreign exchange rates, the uncertainty of market acceptance of new product introductions, the uncertainty of gaining new strategic relationships or locating and capitalizing on strategic opportunities, the uncertainty of timing of private label sales revenues (particularly international customers), FDA and other regulatory review and response times, and other risk factors listed from time to time in the Company's SEC reports and filings, including, without limitation, the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended September 30, 2008 and subsequent reports on Forms 10-Q and 8-K. Readers are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

    Contact: Anthony J. Conway
    President and Chief Executive Officer
    Rochester Medical Corporation
    Phone: (507) 533-9600


'/>"/>
SOURCE Rochester Medical Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Rochester Medical Launches StrataSI(TM) & StrataNF(TM) Next Generation Foley Catheters
2. Rochester Medical Reports Third Quarter Results
3. Rochester Medical Announces Third Quarter 2009 Earnings Conference Call July 30, 2009
4. Purple Communications Dream Bigger Initiative Honors Rochester Physician and Deaf Community Trailblazer
5. Rochester Medical Corporation Set to Join Russell 3000 Index
6. Rochester Medical Reports Second Quarter Results
7. Rochester Medical Announces Second Quarter 2009 Earnings Conference Call April 30, 2009
8. Rochester Medical Renews Share Repurchase Activity
9. University of Rochester Launches iTraining for Emergency Responders
10. Rochester Medical Reports First Quarter Results
11. Rochester study raises new questions about controversial plastics chemical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... , ... May 26, 2017 , ... Dr. Alex Rabinovich, ... to announce a new, informational blog post on insurance options. If a Bay Area ... plans may help save time and money. Visiting an in-network provider for a second ...
(Date:5/26/2017)... , ... May 26, 2017 , ... “THE FLINTHILLS FAMILY-Our Journey to the Cross”: the ... Journey to the Cross” is the creation of published authors, Bob and Margaret Massey. ... to say, he is "panther quick and leather tough." His love for others is ...
(Date:5/26/2017)... ... May 26, 2017 , ... “Just What Happened in the Garden of Eden”: retells the ... of Eden” is the creation of published author, Penelope Colt, mother, trader, horse farmer, artist ... to NYC when she was three. At six, they moved to Dayton, Ohio, where ...
(Date:5/26/2017)... ... May 26, 2017 , ... Water damage to the flooring of several classrooms ... left education officials with a number of critical issues to address before students could ... be accomplished with little or no disruption to class schedules. Second, the project had ...
(Date:5/24/2017)... Ca (PRWEB) , ... May 24, 2017 , ... ... effects and background. Understanind and choosing the most appropriate instruments for research and ... critical in research finding. This webinar will focus on innovations in stereo microscopy ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... 2017  Amy Baxter MD, chief executive officer and ... pain relief, was awarded a 2017 Top 40 Healthcare ... recognized at the MM&M Top 40 Healthcare Transformers dinner ... on May 10, 2017. The dinner followed a ... "beyond the pill."  "Innovation goes beyond invention," ...
(Date:5/10/2017)... Hologic, Inc. (Nasdaq: HOLX ) ... second quarter ended April 1, 2017 .   GAAP ... compared to the prior year period as the sale ... gain, while non-GAAP diluted EPS of $0.50 increased 6.4%.  ... constant currency terms.  Excluding the effects of blood screening ...
(Date:5/10/2017)... Md. , May 10, 2017 CSSi, ... solutions for the clinical research industry, is proud to ... www.CSSiEnroll.com . The new website features both enriched content ... user experience and enhances the company,s already well-established position ... industry. "After many months of hard ...
Breaking Medicine Technology: